What is the expected market size of the France Cancer Biologic Therapy Market in 2024?

The France Cancer Biologic Therapy Market is expected to be valued at 5.5 USD Billion in 2024. Read More

What will be the market value of the France Cancer Biologic Therapy Market in 2035?

By 2035, the France Cancer Biologic Therapy Market is projected to reach a value of 10.0 USD Billion. Read More

What is the expected compound annual growth rate (CAGR) for the France Cancer Biologic Therapy Market from 2025 to 2035?

The market is expected to exhibit a CAGR of 5.585% from 2025 to 2035. Read More

What type of cancer biologic therapy will dominate the market in France by 2035?

Monoclonal Antibodies are anticipated to dominate the market with a value of 4.4 USD Billion by 2035. Read More

How much is the market for Vaccines in the France Cancer Biologic Therapy expected to be in 2035?

The market for Vaccines is expected to be valued at 2.0 USD Billion in 2035. Read More

What are the expected market sizes for Cytokines and Gene Therapy in 2035?

Cytokines are projected to reach 1.4 USD Billion and Gene Therapy is expected to achieve 2.2 USD Billion in 2035. Read More

Who are the key players in the France Cancer Biologic Therapy Market?

Major players include Gilead Sciences, Novartis, and Bristol-Myers Squibb among others. Read More

What is the market value of Monoclonal Antibodies in 2024?

Monoclonal Antibodies are valued at 2.4 USD Billion in 2024. Read More

What are some emerging trends in the France Cancer Biologic Therapy Market?

Emerging trends include the increasing demand for personalized medicine and advancements in gene therapies. Read More

What challenges does the France Cancer Biologic Therapy Market face?

Challenges include high research and development costs and stringent regulatory requirements. Read More

France Cancer Biologic Therapy Market

France Cancer Biologic Therapy Market Research Report: Size, Share, Trend Analysis By Types of Therapy (Monoclonal Antibodies, Vaccines, Cytokines, Gene Therapy), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer), By Administration Route (Intravenous, Subcutaneous, Oral, Intramuscular) and By End Users (Hospitals, Cancer Research Institutes, Pharmaceutical Companies) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025-2035

CAGR

5.59%

2023 Market Size

$ 4.91 Billion

2035 Market Size

$ 10 Billion

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/52694-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

EXECUTIVE SUMMARY
1. Market Overview
2. Key Findings
3. Market Segmentation
4. Competitive Landscape
5. Challenges and Opportunities
6. Future Outlook
MARKET INTRODUCTION
1. Definition
2. Scope of the study
3. Research Objective
4. Assumption
5. Limitations
RESEARCH METHODOLOGY
1. Overview
2. Data Mining
3. Secondary Research
4. Primary Research
5. Primary Interviews and Information Gathering Process
6. Breakdown of Primary Respondents
7. Forecasting Model
8. Market Size Estimation
9. Bottom-Up Approach
10. Top-Down Approach
11. Data Triangulation
12. Validation
MARKET DYNAMICS
1. Overview
2. Drivers
3. Restraints
4. Opportunities
MARKET FACTOR ANALYSIS
1. Value chain Analysis
2. Porter's Five Forces Analysis
3. Bargaining Power of Suppliers
4. Bargaining Power of Buyers
5. Threat of New Entrants
6. Threat of Substitutes
7. Intensity of Rivalry
8. COVID-19 Impact Analysis
9. Market Impact Analysis
10. Regional Impact
11. Opportunity and Threat Analysis
France Cancer Biologic Therapy Market, BY Type of Therapy (USD Billion)
1. Monoclonal Antibodies
2. Vaccines
3. Cytokines
4. Gene Therapy
France Cancer Biologic Therapy Market, BY Cancer Type (USD Billion)
1. Breast Cancer
2. Lung Cancer
3. Colorectal Cancer
4. Prostate Cancer
France Cancer Biologic Therapy Market, BY Administration Route (USD Billion)
1. Intravenous
2. Subcutaneous
3. Oral
4. Intramuscular
France Cancer Biologic Therapy Market, BY End User (USD Billion)
1. Hospitals
2. Cancer Research Institutes
3. Pharmaceutical Companies
4. Competitive Landscape
5. Overview
6. Competitive Analysis
7. Market share Analysis
8. Major Growth Strategy in the Cancer Biologic Therapy Market
9. Competitive Benchmarking
10. Leading Players in Terms of Number of Developments in the Cancer Biologic Therapy Market
11. Key developments and growth strategies
12. New Product Launch/Service Deployment
13. Merger & Acquisitions
14. Joint Ventures
15. Major Players Financial Matrix
16. Sales and Operating Income
17. Major Players R&D Expenditure. 2023
18. Company Profiles
19. Gilead Sciences
20. Financial Overview
21. Products Offered
22. Key Developments
23. SWOT Analysis
24. Key Strategies
25. Novartis
26. Financial Overview
27. Products Offered
28. Key Developments
29. SWOT Analysis
30. Key Strategies
31. Regeneron Pharmaceuticals
32. Financial Overview
33. Products Offered
34. Key Developments
35. SWOT Analysis
36. Key Strategies
37. Ipsen
38. Financial Overview
39. Products Offered
40. Key Developments
41. SWOT Analysis
42. Key Strategies
43. Sanofi
44. Financial Overview
45. Products Offered
46. Key Developments
47. SWOT Analysis
48. Key Strategies
49. Eli Lilly
50. Financial Overview
51. Products Offered
52. Key Developments
53. SWOT Analysis
54. Key Strategies
55. Amgen
56. Financial Overview
57. Products Offered
58. Key Developments
59. SWOT Analysis
60. Key Strategies
61. Servier
62. Financial Overview
63. Products Offered
64. Key Developments
65. SWOT Analysis
66. Key Strategies
67. Merck & Co
68. Financial Overview
69. Products Offered
70. Key Developments
71. SWOT Analysis
72. Key Strategies
73. BristolMyers Squibb
74. Financial Overview
75. Products Offered
76. Key Developments
77. SWOT Analysis
78. Key Strategies
79. AstraZeneca
80. Financial Overview
81. Products Offered
82. Key Developments
83. SWOT Analysis
84. Key Strategies
85. Mylan
86. Financial Overview
87. Products Offered
88. Key Developments
89. SWOT Analysis
90. Key Strategies
91. Pfizer
92. Financial Overview
93. Products Offered
94. Key Developments
95. SWOT Analysis
96. Key Strategies
97. Teva Pharmaceutical
98. Financial Overview
99. Products Offered
100. Key Developments
101. SWOT Analysis
102. Key Strategies
103. Roche
104. Financial Overview
105. Products Offered
106. Key Developments
107. SWOT Analysis
108. Key Strategies
109. Appendix
110. References
111. Related Reports
112. LIST Of tables
LIST OF ASSUMPTIONS
France Cancer Biologic Therapy Market SIZE ESTIMATES & France Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2019-2035 (USD Billions)
France Cancer Biologic Therapy Market SIZE ESTIMATES & France Cancer Biologic Therapy Market, BY CANCER TYPE, 2019-2035 (USD Billions)
France Cancer Biologic Therapy Market SIZE ESTIMATES & France Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)
France Cancer Biologic Therapy Market SIZE ESTIMATES & France Cancer Biologic Therapy Market, BY END USER, 2019-2035 (USD Billions)
1. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
2. ACQUISITION/PARTNERSHIP
3. LIST Of figures
MARKET SYNOPSIS
1. FRANCE CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY TYPE OF THERAPY
2. FRANCE CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY CANCER TYPE
3. FRANCE CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY ADMINISTRATION ROUTE
4. FRANCE CANCER BIOLOGIC THERAPY MARKET ANALYSIS BY END USER
KEY BUYING CRITERIA OF CANCER BIOLOGIC THERAPY MARKET
1. RESEARCH PROCESS OF MRFR
DRO ANALYSIS OF CANCER BIOLOGIC THERAPY MARKET
1. DRIVERS IMPACT ANALYSIS: CANCER BIOLOGIC THERAPY MARKET
2. RESTRAINTS IMPACT ANALYSIS: CANCER BIOLOGIC THERAPY MARKET
3. SUPPLY / VALUE CHAIN: CANCER BIOLOGIC THERAPY MARKET
France Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2025 (% SHARE)
France Cancer Biologic Therapy Market, BY TYPE OF THERAPY, 2019 TO 2035 (USD Billions)
France Cancer Biologic Therapy Market, BY CANCER TYPE, 2025 (% SHARE)
France Cancer Biologic Therapy Market, BY CANCER TYPE, 2019 TO 2035 (USD Billions)
France Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2025 (% SHARE)
France Cancer Biologic Therapy Market, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)
France Cancer Biologic Therapy Market, BY END USER, 2025 (% SHARE)
France Cancer Biologic Therapy Market, BY END USER, 2019 TO 2035 (USD Billions)
1. BENCHMARKING OF MAJOR COMPETITORS

Certified Researchers

Customize Report

France Cancer Biologic Therapy Market Segmentation

France Cancer Biologic Therapy Market By Type of Therapy (USD Billion, 2019-2035)
- Monoclonal Antibodies
- Vaccines
- Cytokines
- Gene Therapy

France Cancer Biologic Therapy Market By Cancer Type (USD Billion, 2019-2035)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer

France Cancer Biologic Therapy Market By Administration Route (USD Billion, 2019-2035)
- Intravenous
- Subcutaneous
- Oral
- Intramuscular

France Cancer Biologic Therapy Market By End User (USD Billion, 2019-2035)
- Hospitals
- Cancer Research Institutes
- France Cancer Biologic Therapy Market Companies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”